RxDoctor Payments DataLook up a doctor →

Breyanzi: payments to doctors

Payments that named Breyanzi as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$1M
Providers
1,153
Transactions
2,269
Average per transaction
$447

The per-transaction average — $447 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,153 providers the average total is $879, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
E.r. Squibb & Sons, L.L.C.$979,03596.6%
Bristol Myers Squibb$34,3773.4%
← All drugs & devices